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Hyperpolarized 13C Spectroscopic 
Evaluation of Oxidative Stress in a 
Rodent Model of Steatohepatitis
David M. Wilson1, Valentina Di Gialleonardo2,3, Zhen J. Wang1, Valerie Carroll1,  
Cornelius Von Morze1, Andrew Taylor1, Victor Sai1, Mark VanCriekinge1, Robert Bok1, 
Michael A. Ohliger1 & Kayvan R. Keshari2,3,4
Nonalcoholic fatty liver disease (NAFLD) has become highly prevalent, now considered the most 
common liver disease in the western world. Approximately one-third of patients with NASH develop 
non-alchoholic steatohepatitis (NASH), histologically defined by lobular and portal inflammation, 
and accompanied by marked oxidative stress. Patients with NASH are at increased risk for cirrhosis 
and hepatocellular carcinoma, and diagnosis currently requires invasive biopsy. In animal models of 
NASH, particularly the methionine-choline deficient (MCD) model, profound changes are seen in redox 
enzymes and key intracellular antioxidants. To study antioxidant status in NASH non-invasively, we 
applied the redox probe hyperpolarized [1-13C] dehydroascorbic acid (HP DHA), which is reduced to 
Vitamin C (VitC) rapidly in the normal liver. In MCD mice, we observed a significant decrease in HP DHA 
to VitC conversion that accompanied hepatic fat deposition. When these animals were subsequently 
placed on a normal diet, resonance ratios reverted to those seen in control mice. These findings suggest 
that HP DHA, a potentially clinically translatable imaging agent, holds special promise in imaging NASH 
and other metabolic syndromes, to monitor disease progression and response to targeted therapies.
Nonalcoholic fatty liver disease (NAFLD) is now a highly prevalent disease in Western industrialized nations, 
often accompanied by other metabolic syndromes, namely obesity, insulin resistance, and hyperlipidemia1. A 
recent survey-based study found a 30% prevalence of NAFLD in the United States between 2011 and 20122. The 
progression of simple steatosis to non-alcoholic steatohepatitis (NASH) disease shows histologic findings similar 
to that seen in alcoholic liver disease namely ballooning degeneration, and inflammation in hepatocytes3. This 
progression is of particular interest, since the latter is associated with cirrhosis and/or hepatocellular carcinoma 
(HCC), which may both be fatal. In NASH, triglyceride accumulation in the liver is accompanied by a significant 
inflammatory response, excess production of extracellular matrix, and oxidative stress4,5. Reactive oxygen species 
(ROS) can directly damage the cell via membrane lipid peroxidation, and exert redox-dependent metabolic alter-
ations6. These metabolic changes are enforced by regulation of key enzymes, redox-dependent post-translational 
protein modifications, and control of nuclear receptors including the peroxisome proliferator-activated receptor 
(PPAR), proliferator-activated receptor-gamma coactivator-1 (PCG-1) and sterol response element binding pro-
tein (SREBP) families7–9.
Changes in redox status have been explored in numerous animal models of NASH, including those harboring 
genetic defects (ob/ob), or generated by feeding animals an altered diet10. The model that best recapitulates the 
histopathological features of NASH is the methionine-choline deficient (MCD) dietary model, which is accom-
panied by steatohepatitis, inflammation, and oxidative stress11,12. The dynamics of oxidative/nitrosative stress in 
the MCD model were recently studied at 2,4, and 6-week time-points showing reductions in liver catalase and 
superoxide dismutase (SOD) activities, and subtle but statistically significant elevations of total nitrates/nitrites 
(NOx)13. Both metabolic and proteomic analyses have been performed on MCD mice, yielding a large num-
ber of correlates to the observed oxidative injury in NASH14,15. The proteomic study conducted by Lee et al. by 
MALDI-TOF analysis showed that several of the differentially expressed proteins in MCD mice were related to 
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redox homeostasis. These included proteins directly involved in the detoxification of reactive oxygen and reactive 
nitrogen species (glutathione peroxidase, superoxide dismutase and glutathione S-transferase), proteins func-
tioning in cellular protection against oxidative stress (peroxiredoxins), and the microsomal enzyme cytochrome 
P450 2E1 (CYP2E1). The study showed a dramatic increase CYP2E1 in MCD-fed mice compared to normal 
diet, reinforcing its role in generation of reactive oxygen species16. Finally, some studies have shown a decreased 
concentration of reduced glutathione (GSH) in MCD-fed mice13,17,18, although this decrease was not observed at 
two weeks13.
Given the importance of oxidative stress in promoting hepatic injury in NASH, we studied the MCD-fed 
mice using a new spectroscopic method, namely magnetic resonance spectroscopy (MRS) using hyperpolarized 
[1-13C] dehydroascorbic acid (HP DHA), the oxidized form of Vitamin C (VitC) as an in vivo redox sensor19. 
Hyperpolarized 13C MRS is a relatively new technique by which the spin polarization of a nucleus is enhanced 
by several orders of magnitude (up to 105) thereby allowing real-time study of in vivo metabolism20,21. Recently, 
the technique has been used in prostate cancer patients, demonstrating its potential for translation into routine 
clinical practice22. We developed HP DHA to study the changes in redox homeostasis that accompany cancer 
and other diseases (Fig. 1). HP DHA is transported rapidly into cells via glucose transporters (predominantly 
GLUT 1,3,4) and reduced to VitC in both cell and animal models19,23. This conversion is believed to occur in a 
GSH-dependent manner, catalyzed by number of enzymes including glutaredoxin, protein disulfide isomerase, 
and glutathione transferases24–27. We have also observed decreased HP DHA to VitC conversion in a model of dia-
betic nephropathy using db/db mice, and correlated this finding both to decreased GSH and increased NADPH 
oxidase 4 (Nox4) expression, reflecting increased superoxide generation28. For these studies, the rate of HP DHA 
to VitC conversion is best characterized by the resonance ratios derived from in vivo 13C spectra, for example 
VitC/DHA or VitC/VitC + DHA. This conversion occurs within seconds in many tissues, reflecting rapid reduc-
tion of HP DHA by the cellular antioxidant network.
In the present study, we investigated NASH in the MCD-diet murine model using HP DHA and correlated 
spectroscopic data with hepatic steatosis. Fat accumulation in the liver was demonstrated both histologically and 
using 1H MRI fat-water imaging at ultra high-field (14 T). MCD-diet mice were also studied following return to 
a normal diet (MCDr or “recovery” group). Rapid imaging using HP DHA in a rodent model of NASH provided 
a means of demonstrating oxidative stress non-invasively and the showing the restoration of liver cell redox 
capacity in MCDr mice.
Results
MCD-fed mice showed significant lipid accumulation at two weeks as evaluated by 1H MRI at 
14 T and histologic staining. Animals fed the MCD-diet were characterized by decreased body weight and 
liver size at two weeks, consistent with prior reports (Fig. 2A). In the MCD group, the average hepatic volume 
was 0.57 ± 0.15 cm3 (0.69 ± 0.17 cm3 in the control group) and the average weight was 22.5 ± 3.8 g (30.8 ± 2.9 g 
in the control group), representing a 27% decrease (p < 0.05). The presence of oxidative injury in MCD mice was 
demonstrated via a catalase activity assay, and anti 8-OHdG monoclonal antibody staining (Figure Supp Fig. 1). 
These studies were consistent with prior reports showing decreased catalase activity and increased 8-OHdG in 
MCD mice13,29. Fat content of the liver was investigated by 1H MRI, routine histology, and specialized staining. 
Steatosis was first demonstrated in vivo using 1H MRI fat-water technique30, showing a significant increase in 
hepatic fat content (Fig. 2B, C). In the MCD group, the hepatic fat content was 50.3 ± 11.1%, versus 16.9 ± 5.4% in 
the control group corresponding to a 3-fold increase (p < 0.05). In contrast, conventional T2-weighted sequences 
showed minimal differences in parenchymal signal between MCD and control groups. Following sacrifice, par-
affin-embedded sections were studied using hematoxyln and eosin staining, showing predominantly microvesic-
ular steatosis, without evidence of fibrosis (Fig. 2D). This appearance is consistent with the study published by 
Jorgacevic et al., which explicitly studied the dynamics of histologic changes in MCD-fed animals13. The liver was 
also studied using Oil Red O dye, a lysochrome diazo dye used to stain triglycerides and lipids. Marked accumu-
lation of the stain was observed for MCD-derived liver samples.
Figure 1. Imaging oxidative stress in vivo using HP [1-13C] DHA. The probe is polarized using the dynamic 
nuclear polarization (DNP) technique, in a concentrated solution containing an unpaired electron source. 
Following dissolution and intravenous injection, HP [1-13C] DHA is transported rapidly into cells via glucose 
(GLUT) transporters. Enzyme mediated two-electron reduction of [1-13C] DHA to [1-13C] VitC is detected 
spectroscopically. This conversion depends on cellular reducing capacity, which is diminished in the setting of 
oxidative stress.
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Hyperpolarized 13C dehydroascorbate spectroscopy reveals decreased HP DHA to VitC conver-
sion in MCD-fed mice relative to controls. The redox sensor HP DHA was used to evaluate altered redox 
capacity in MCD-diet mice, using a ratiometric, 3D spectroscopic technique. In this case a single time-point 
13C magnetic resonance spectroscopic imaging (MRSI) study was performed to detect HP DHA to VitC con-
version. Following intravenous injection of HP DHA, rapid conversion to VitC occurs in a matter of seconds, 
particularly in tissues with high exposure to oxidative stress including the brain, kidneys and liver. The rate of 
HP DHA to VitC conversion has been previously correlated with components of the redox network in animal 
models of cancer and diabetes19,23,28. As discussed previously, there is severe disruption of redox homeostasis in 
the MCD-deficient model, as evidenced by the downregulation of numerous enzymes involved in detoxification 
of reactive oxygen and reactive nitrogen species. We speculated that these numerous alterations might be detected 
by our non-invasive and potentially translatable HP MRS method.
In control mice, intravenous administration of HP DHA followed by 13C MRSI revealed similar VitC/
VitC + DHA and VitC/DHA metabolite ratios to those previously reported. In contrast, these ratios were mark-
edly lower in MCD mice as shown in Fig. 3. The average VitC/VitC + DHA peak ratio was 0.49 ± 0.02 for the 
control group and 0.32 ± 0.03 for the MCD group (35% decrease, p < 0.05), while the average VitC/DHA metab-
olite ratio was 0.97 ± 0.07 for the control group and 0.49 ± 0.06 for the MCD group (49% decrease, p < 0.05) In 
all cases, anatomic T2-weighted 1H imaging was performed during the same session to confidently assign voxels 
to the hepatic parenchyma.
MCD recovery mice showed a complete return to baseline by HP DHA MRS despite persistent 
elevated hepatic lipids. Having shown that the redox sensor HP DHA is responsive to hepatic injury in the 
MCD-diet model, we studied recovered mice following return to a normal diet (MCDr group). Numerous other 
modulations of the redox network in MCD mice have been studied, using artificial enzymes, vitamins, and other 
natural products. These therapies have included Mn-salen complexes, Vitamin C, Chunggan extract, hydrogen 
sulfide, hypotaurine and curcurmin14,15,31–33. In our study, mice originally fed the MCD-diet were allowed to 
recover for one week on a normal diet (n = 4, MCDr group). The animals were imaged by 13C MRSI following 
injection of HP DHA with VitC/VitC + DHA and VitC/DHA resonance ratios again calculated for hepatic voxels. 
The results are shown in Fig. 4, where representative HP spectra for the MCDr group are shown, and the metab-
olite ratios derived are compared to those for the MCD group. These data showed nearly identical metabolite 
ratios to those calculated for the control group, with the average VitC/VitC + DHA 0.47 ± 0.05 and the average 
VitC/DHA 0.95 ± 0.13 (p > 0.05 versus C group). Sacrificed MCDr mice showed mild histologic improvement 
in hepatic steatosis versus the MCD group, but significantly elevated lipid content relative to control animals 
(Fig. 4C). Fat-water 1H imaging of MCDr animals showed an average fat content of 34.0 ± 31.0%, representing a 
2-fold increase versus the control group (p < 0.05), but no significant change versus MCD animals. In addition, 
the presence of thiols was assessed using the Mercury Orange technique showing depletion in MCD animals and 
recovery in MCDr mice (Fig. 4D)34. These key findings lead to a model of MCD induced oxidative stress (Fig. 5).
Discussion
This study demonstrated that 13C MR spectroscopy using HP DHA is a sensitive indicator of metabolic alterations 
in the MCD-diet model of NASH. Given the extensive data implicating oxidative stress in this model, as well 
as what is known about the mechanism of HP DHA to VitC conversion, it is likely that altered redox status in 
MCD-mice is responsible for the observed differences in metabolite ratios. Oxidative stress in MCD-mice occurs 
via numerous mechanisms including decreased concentrations of intracellular reducing agents, decreased expres-
sion of key antioxidant defense enzymes (GPx, SOD, GST, and members of Prx family), and enhanced activity of 
Figure 2. Lipid content of the liver in MCD-diet mice investigated by 1H MRI and histologic analysis.  
(a) Consistent with prior reports, a 27% decrease in total body weight was observed for MCD mice (b) Fat-
water 1H imaging revealed a 3-fold increase in hepatic fat content. (c) Representative 1H MRI images from 
normal and MCD-diet mice by standard T2-weighted and fat-water imaging. Studies were conducted on a 
vertical wide-bore 14T magnet. While only subtle changes were observed using the T2-weighted sequence, 
dramatic hepatic steatosis was seen using the fat-water method. (d) Representative histologic sections using 
both hematoxylin and eosin as well as Oil Red O staining. The former shows microvesicular steatosis, while the 
latter shows significant lipid staining.
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microsomal enzymes especially CYP2E1. An interesting finding of our study was decreased overall thiol staining 
in the livers of MCD mice versus controls, in the absence of significant differences in GSH. This result may reflect 
the oxidation of protein thiols (for example thioredoxins), which some studies suggest represent the largest cel-
lular redox pool35.
Given the complexity of the intracellular redox network, it is difficult to identify which components are pri-
marily responsible for in vivo HP DHA to VitC reduction. HP DHA has been previously studied in lymphoma 
(EL4) cells23, the transgenic adenocarcinoma of the mouse prostate (TRAMP) model36, and the db/db murine 
model of diabetic nephropathy28. These studies also analyzed specific components of the redox network and 
found correlations with the observed in vivo behavior of HP DHA. Given the results of these studies as well as 
what is known about DHA metabolism, HP DHA is probably best considered an oxidative challenge to tissues, 
with altered conversion seen in conditions for which the antioxidant defense system is compromised. Specific 
modulations of the redox network, via transgenic mice and gene silencing in cell culture, are currently being 
used to further elucidate the in vivo mechanisms of HP DHA and other novel redox probes. In addition, technical 
aspects of the HP DHA-MRI experiment are being refined, in particular to address toxicity in vivo37. Specifically, 
polarization and MR acquisition methods will require improvement, to allow the 13C DHA dose reduction needed 
for patient studies.
In summary, HP DHA in a NASH model allowed us to assess the oxidative damage associated with disease 
progression and its normalization upon return to a normal diet. Moreover, in recovering mice this effect was 
reversed before the resolution of intrahepatic lipid deposits, suggesting that modulations of the antioxidant net-
work and lipid accumulation may be non-synchronous in NASH. This finding has great implications both for 
potential use of HP DHA in the clinic as well as the development of novel therapeutic strategies to address NASH.
Methods
Animals and experimental design. All procedures were approved by the Institutional Animal Care and 
Use Committee. Veterinary services for the study were provided by the UCSF Laboratory Animal Resource 
Center (LARC) and all studies were performed in accordance with UCSF guidelines regarding animal housing, 
pain management, and euthanasia. The experiments used male FVB/NJ mice with an initial weight of 25–35 
grams. The animals were kept under standard laboratory conditions (temperature 22 ± 2°C, relative humidity 
50 ± 10%, 12 h/12 h light-dark cycle). All animals were fed with a control diet for at least 1 week (acclimatization 
period). 3 groups of animals were studied; Group 1: control group (C; n = 5); group 2: MCD-diet group fed for 2 
weeks (MCD; n = 7); group 3: MCD-diet group fed for 2 weeks, followed by 1 week return to normal diet (MCDr; 
n = 4). Standard diet contained 2 g/kg of choline chloride and 3 g/kg of methionine, while the MCD diet had 
identical composition as the normal chow but without methionine and choline (Dyets Inc., Supp Fig. 2). Animals 
in each group were subjected to HP DHA 13C MRS, 1H fat-water imaging, and histologic evaluation following 
sacrifice.
Figure 3. Study of control and MCD groups by HP DHA 13C MRSI. (a) Representative 13C spectra obtained 
from the livers of MCD-diet mice using HP DHA at two weeks. Voxels corresponding to the liver for both C 
and MCD mice are juxtaposed with T2-weighted images acquired at the time of the HP experiment. Resonances 
corresponding to [1-13C] DHA and [1-13C] VitC are depicted, with a clear decrease in the HP VitC to DHA 
ratio observed in the MCD-diet animals. (b) Scatter plots showing the metabolite ratios derived from animal 
experiments for the normal and MCD groups, expressed both as VitC/VitC + DHA and VitC/DHA. These 
ratios decreased significantly by 35% and 49% respectively (p < 0.05 for both) in the livers of MCD-diet animals 
relative to controls.
www.nature.com/scientificreports/
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Figure 4. Study of recovery phase animals (MCDr group) by HP DHA. (a) Representative 13C spectra 
obtained from the MCD group are compared to those obtained from mice first fed the MCD diet, then normal 
chow for 1 week. The HP DHA to VitC resonance ratios in the recovery group appear similar to those obtained 
for controls. (b) Bar graphs obtained for MCDr mice show significant increases in VitC/VitC + DHA and VitC/
DHA ratios (p < 0.05) following return to a normal diet, which were not significantly different from baseline 
mice. (c) Although body weights in MCDr mice returned to normal, there was still significant hepatic steatosis 
(30%) seen in these animals, 2-fold that seen in the control group. (d) Mercury Orange staining showing 
decreased thiol content in MCD mice. Significant normalization was seen in the recovery group.
Figure 5. Model of oxidative stress imaging using HP DHA in the setting of NASH. In MCD mice, markedly 
decreased HP DHA to VitC conversion was seen compared to controls. The 13C spectra returned to baseline 
following return to a normal diet, while hepatic fat content remained significantly elevated.
www.nature.com/scientificreports/
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Synthesis, preparation and polarization of [1-13C] dehydroascorbic acid. [1-13C] DHA (Isotec, 
Miamisburg, OH) was synthesized using a published method, by air oxidation of [1-13C] ascorbic acid in the 
presence of catalytic amounts of copper (II) acetate38. A 2.2 M solution of [1-13C] DHA in dimethyacetamide 
(DMA) containing 15 mM OX063 trityl radical (Oxford Instruments) was hyperpolarized on a HyperSense DNP 
instrument (Oxford Instruments) as previously described19. The frozen sample was dissolved in distilled water 
containing 0.3 mM EDTA.
Hyperpolarized 13C magnetic resonance spectroscopic imaging. In vivo studies were performed using 
a 3T MRI scanner (GE Healthcare) equipped with the MNS (multinuclear spectroscopy) hardware package. The RF 
coil used in these experiments was a dual-tuned 1H-13C coil with a quadrature 13C channel and linear 1H channel 
construction as reported previously39. Prior to 13C studies, 3-plane T2-weighted images were acquired for anatomic 
localization (TE = 100 ms, TR = 4 s, 6 averages) using a standard fast spin echo sequence. These images were used to 
calculate liver volumes for the control, MCD, and MCDr groups. Single time-point 13C MRSI studies were carried 
out as previously published39. 350 μ L of a hyperpolarized 15 mM [1-13C] DHA solution were injected similar to 
previously described methods for [1-13C] pyruvate. An 8 M 13C urea phantom in a sealed tube was placed within 
the sensitive volume of the RF coil. For the 13C 3D MRSI studies, the imaging sequence was initiated 10 s following 
completion of a 15 s injection (representing a total delay of 225 ms). 13C 3D MRSI used a variable flip angle scheme, 
matrix size of 8 × 8 × 16 (voxel size of 5 mm isotropic), TR = 105 ms, spectral bandwidth = 25000 Hz, 2538 points.
Fat-water imaging at 14T. For all groups (control, MCD and MCDr), high-resolution T2 and fat-water 
imaging was conducted at 14T using a Varian WB600 micro-imager and 40 mm 1H millipede coil (Varian 
Instruments, Palo Alto, CA). Lipid percentage maps were calculated from fat and water images acquired with a 
conventional spin-echo sequence using the Dixon method30,40.
Histopathology/Activity assays. Liver tissues from the control, MCD and MCDr groups were 
studied using Hematoxylin and Eosin (H&E), Oil Red O, and Mercury Orange staining. Formalin-fixed, 
paraffin-embedded liver tissues were sectioned at 4 μ m and stained with Hematoxylin and Eosin; frozen tissues 
embedded in OCT (optimum cutting media) were sectioned at 10 μ m and stained for Oil Red O and Mercury 
Orange using standard protocols34,41. Anti 8-OHdG staining was performed as reported previously28. Catalase 
activity was determined via a standard method on homogenized liver tissue13.
Data analysis and statistical considerations. In vivo MRSI data were processed using custom software 
written in IDL 8 (ITT Visual Information Solutions) and Matlab 2009b (MathWorks). DHA and Vitamin C res-
onances were integrated and peak heights were used to calculate relevant ratios. In order to assign voxels to the 
liver, 100% of a given voxel corresponded to the tissue of interest as validated by the corresponding T2-weighted 
image. Metabolite ratios were calculated for individual voxels using HP 13C DHA and Vitamin C resonances, 
using relative peak heights. Average metabolite ratios (VitC/VitC + DHA and VitC/DHA) for liver tissue in indi-
vidual animals were then calculated, and these values averaged for control, MCD and MCDr groups. For all 
animals, the number of voxels (per animal) used to determine the VitC/VitC + DHA and VitC/DHA ratios in 
the liver ranged between 2–4. All statistics were calculated using JMP software (SAS Corporation, Cary, NC). 
Significance was reported using a two-sided Student’s t-test for all comparisons and a p-value < 0.05. All data are 
reported as mean ± standard error, with corresponding error bars depicted in the Figures.
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